{{ $DoctorName }} @if (isset(session()->get('doctor')['vCentralCode'])) {{ session()->get('doctor')['vCentralCode'] }} @endif
@if (isset(session()->get('doctor')['vCentralCode']))
Logout
@endif

{{ $ActivityTypeName }}

{{ $ActivityName }}

@csrf
@if (isset(session()->get('doctor')['vCentralCode']))
Back
@else
@endif

A Survey to assess epidemiology and Treatment Practices in Management of Melasma among Dermatologists in India

Survey Questionnaire Form
Doctor’s details

Questionnaire

  1. Out of total patients you see in your clinic/hospital, what percent of your patients seek consultation for complaints of facial hyperpigmentation? *

  2. What are the top 3 common facial hyperpigmentary conditions that you see in your clinic/hospital? *
  3. Out of total patients of facial hyperpigmentation, what % of these patients are affected by melasma? *

  4. What is the most common clinical presentation of melasma you see in your practice *

  5. What is the Male: female ratio you see in Melasma in your practice? *
  6. What percentage of your patients have a family history of melasma? *

  7. In what % of your patients with melasma, do you recommend sunscreen? *

  8. What are the properties you look for while choosing a sunscreen in your patients with melasma? (Kindly select top 5 options) *

  9. Do you prefer to use triple combination in your patients melasma? *

  10. If yes, for how long do you prescribe triple combination in your patients with melasma?

  11. What do you prefer as maintenance therapy in you patients with melasma and for how long? (2-3 preferred options can be provided) *
  12. Do you use tranexamic acid in your patients with melasma? *

  13. Which route of administration, do you prefer for tranexamic acid? *

  14. In what percentage of your patients with melasma some or the other procedures are required? *

  15. How do you assess the response to treatment in your patients with melasma? (More than one option can be selected) *

  16. When do you see relapse in patients with melasma after stopping treatment? *